A Phase 2 Placebo Controlled, Clinical Trial Designed to Assess the Efficacy, Safety and Dose Response Characterisation of STS01 for the Treatment of Mild-moderate Alopecia Areata (AA)

Conditions: Alopecia Areata Interventions: Drug: STS01; Drug: Placebo Sponsors: Soterios Ltd Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials